Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

Bermuda Health Council Accepted Into RedETSA

March 18, 2019

http://bernews.com/2019/03/bhec-redetsa/

Posted in: Uncategorized

Post navigation

← Health Canada & HTA Body CADTH To Offer Parallel Scientific Advice
Canada to create national drug agency to help cut cost of medicines →

News

The new definition of HTA: A milestone in international collaboration
Impact of a Global Pandemic on Health Technology Assessment
NEW HTAi – ISPOR Joint Deliberative Processes for HTA Task Force
Strategic collaboration announced by NICE and Health Technology Wales
NICE and LSE announce new Executive MSc in Evaluation of Health Care Interventions and Outcomes degree program, starting in April 2020
Why HTA and Pooled Purchasing Must Be at the Heart of Global Health Transitions
Health Technology Assessment Around the World: Broadening the Understanding of Cross-Country Differences
Ghana’s HTA agenda and UHC, what difference could HTA make?
AMCP releases the AMCP Format for Formulary Submissions, version 4.1
The ‘Top 10’ Challenges for Health Technology Assessment: INAHTA Viewpoint

Twitter

Tweets about #HTA

#HTA

AlohaBruceAlohaBruce@AlohaBruce·
9h

In Hawaii, trying to revive tourism while keeping locals safe #hawaii #travel #vactions #hta #gohawaii
http://ow.ly/waZW50DaxW1

Reply on Twitter 1350820254277005313Retweet on Twitter 1350820254277005313Like on Twitter 13508202542770053131Twitter 1350820254277005313
SVRAlifeSVRA@SVRAlife·
23h

Who doesn't love a little #HistoricTransAm action?! Where & when was the first time you saw @GoTransAm in action? @bigmchnvodka has the opening lap of last year's #HTA race at @sebringraceway. 🏎💨🏁

#vintageracing

Reply on Twitter 1350603033655320579Retweet on Twitter 13506030336553205791Like on Twitter 13506030336553205795Twitter 1350603033655320579
CADTH_ACMTSCADTH@CADTH_ACMTS·
15 Jan

We’re inviting stakeholder feedback on a draft recommendation of nivolumab (Opdivo) and ipilimumab (Yervoy) for the treatment of Non-small cell #LungCancer.

Deadline for feedback is January 22, 2021 👉 https://cadth.info/2XLCo6u #HTA #oncology

Reply on Twitter 1350152028224446472Retweet on Twitter 1350152028224446472Like on Twitter 1350152028224446472Twitter 1350152028224446472
Load More...
Privacy Policy | Disclaimer
Copyright © 2021 ISPOR – The Professional Society for Health Economics and Outcomes Research